Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126189581 | 12618958 | 1 | I | 20160212 | 20160728 | 20160803 | 20160803 | EXP | US-SEATTLE GENETICS-2016SGN01182 | SEATTLE GENETICS | 0.00 | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126189581 | 12618958 | 1 | PS | brentuximab vedotin | BRENTUXIMAB VEDOTIN | 1 | Intravenous (not otherwise specified) | 1.8 MG/KG, Q21D | 2 | MG/KG | U | U | 125388 | 1.8 | MG/KG | INJECTION | |||
| 126189581 | 12618958 | 2 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 25 MG/M2, Q21D | 25 | MG/M2 | U | 0 | 25 | MG/M**2 | INJECTION | ||||
| 126189581 | 12618958 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 125 MG/M2, Q21D | 125 | MG/M2 | U | 0 | 125 | MG/M**2 | INJECTION | ||||
| 126189581 | 12618958 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG/M2, Q21D | 20 | MG/M2 | U | U | 0 | 20 | MG/M**2 | ||||
| 126189581 | 12618958 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 600 MG/M2, QCYCLE | U | U | 0 | 600 | MG/M**2 | INJECTION | /cycle | ||||
| 126189581 | 12618958 | 6 | SS | Vincristine | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1.4 MG/M2, QCYCLE | U | U | 0 | 1.4 | MG/M**2 | INJECTION | /cycle |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126189581 | 12618958 | 1 | Hodgkin's disease |
| 126189581 | 12618958 | 2 | Hodgkin's disease |
| 126189581 | 12618958 | 3 | Hodgkin's disease |
| 126189581 | 12618958 | 4 | Hodgkin's disease |
| 126189581 | 12618958 | 5 | Hodgkin's disease |
| 126189581 | 12618958 | 6 | Hodgkin's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126189581 | 12618958 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126189581 | 12618958 | Acute kidney injury | |
| 126189581 | 12618958 | Cardiac failure | |
| 126189581 | 12618958 | Colitis | |
| 126189581 | 12618958 | Ejection fraction decreased | |
| 126189581 | 12618958 | Hypernatraemia | |
| 126189581 | 12618958 | Hypokalaemia | |
| 126189581 | 12618958 | Respiratory failure | |
| 126189581 | 12618958 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126189581 | 12618958 | 1 | 20160203 | 20160203 | 0 | |
| 126189581 | 12618958 | 2 | 20160203 | 20160204 | 0 | |
| 126189581 | 12618958 | 3 | 20160203 | 20160205 | 0 | |
| 126189581 | 12618958 | 4 | 20160203 | 20160206 | 0 | |
| 126189581 | 12618958 | 5 | 20160203 | 20160204 | 0 | |
| 126189581 | 12618958 | 6 | 20160210 | 20160210 | 0 |